Class Action Lawsuit Filed Against Hims & Hers Health, Inc.
A class action lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS), alleging securities fraud and deceptive business practices by the company and certain officers or directors. The case is being handled by Pomerantz LLP, which encourages affected investors to contact them before November 2, 2026, for potential appointment as Lead Plaintiff. The lawsuit follows a July 29, 2026 announcement from the Federal Trade Commission (FTC), which filed its own suit against Hims & Hers. The FTC alleges that the company shared sensitive health data with third-party advertising platforms like Meta and Snap despite claims of maintaining user privacy. It also accuses Hims & Hers of deceptive billing practices by charging for prescriptions immediately after intake forms are submitted, contrary to what users were told. On July 29, news of these allegations caused Hims & Hers' stock price to drop $4.32 per share (14.73%) and close at $25.00.
Topics: data privacy violations FTC lawsuit securities fraud